140 related articles for article (PubMed ID: 24030740)
1. Maspin expression and melanoma progression: a matter of sub-cellular localization.
Martinoli C; Gandini S; Luise C; Mazzarol G; Confalonieri S; Giuseppe Pelicci P; Testori A; Ferrucci PF
Mod Pathol; 2014 Mar; 27(3):412-9. PubMed ID: 24030740
[TBL] [Abstract][Full Text] [Related]
2. Maspin expression in the invasive margin of primary melanomas may reflect an aggressive tumor phenotype.
Pföhler C; Knöpflen T; Körner R; Vogt T; Rösch A; Müller CS
J Dtsch Dermatol Ges; 2013 Oct; 11(10):993-9. PubMed ID: 23848940
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival.
Slipicevic A; Holm R; Emilsen E; Ree Rosnes AK; Welch DR; Mælandsmo GM; Flørenes VA
BMC Cancer; 2012 Feb; 12():73. PubMed ID: 22356677
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of cytoplasmic p27 expression in human melanoma.
Chen G; Cheng Y; Zhang Z; Martinka M; Li G
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2212-21. PubMed ID: 21828232
[TBL] [Abstract][Full Text] [Related]
5. Cytoplasmic and nuclear maspin expression in lung carcinomas: an immunohistochemical study using tissue microarrays.
Zheng HC; Saito H; Masuda S; Wang ZG; Takano Y
Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):459-65. PubMed ID: 18665036
[TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic Skp2 expression is increased in human melanoma and correlated with patient survival.
Chen G; Cheng Y; Zhang Z; Martinka M; Li G
PLoS One; 2011 Feb; 6(2):e17578. PubMed ID: 21386910
[TBL] [Abstract][Full Text] [Related]
7. Nestin expression is associated with aggressive cutaneous melanoma of the nodular type.
Ladstein RG; Bachmann IM; Straume O; Akslen LA
Mod Pathol; 2014 Mar; 27(3):396-401. PubMed ID: 24030749
[TBL] [Abstract][Full Text] [Related]
8. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma.
Bachmann IM; Straume O; Puntervoll HE; Kalvenes MB; Akslen LA
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8606-14. PubMed ID: 16361544
[TBL] [Abstract][Full Text] [Related]
9. Decreased immunoreactive maspin expression in intermediate thickness and thick primary melanoma lesions.
Vereecken P; Reynaert S; Lalmand MC; Zouaoui-Boudjeltia K; Heenen M; Van Den Heule B; Petein M
J Int Med Res; 2006; 34(1):52-7. PubMed ID: 16604823
[TBL] [Abstract][Full Text] [Related]
10. Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma.
Maelandsmo GM; Holm R; Nesland JM; Fodstad Ø; Flørenes VA
Clin Cancer Res; 2003 Aug; 9(9):3383-8. PubMed ID: 12960126
[TBL] [Abstract][Full Text] [Related]
11. Nuclear maspin expression correlates with the CpG island methylator phenotype and tumor aggressiveness in colorectal cancer.
Kim JH; Cho NY; Bae JM; Kim KJ; Rhee YY; Lee HS; Kang GH
Int J Clin Exp Pathol; 2015; 8(2):1920-8. PubMed ID: 25973084
[TBL] [Abstract][Full Text] [Related]
12. Maspin expression, angiogenesis, prognostic parameters, and outcome in malignant melanoma.
Chua R; Setzer S; Govindarajan B; Sexton D; Cohen C; Arbiser JL
J Am Acad Dermatol; 2009 May; 60(5):758-66. PubMed ID: 19389518
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesis.
Li J; Cheng Y; Tai D; Martinka M; Welch DR; Li G
Oncogene; 2011 Feb; 30(8):896-906. PubMed ID: 20935672
[TBL] [Abstract][Full Text] [Related]
14. Nuclear, compared with combined nuclear and cytoplasmic expression of maspin, is linked in lung adenocarcinoma to reduced VEGF-A levels and in Stage I, improved survival.
Frey A; Soubani AO; Adam AK; Sheng S; Pass HI; Lonardo F
Histopathology; 2009 Apr; 54(5):590-7. PubMed ID: 19309490
[TBL] [Abstract][Full Text] [Related]
15. Maspin expression patterns differ in the invasive versus lepidic growth pattern of pulmonary adenocarcinoma.
Lonardo F; Guan H; Dzinic S; Sheng S
Histopathology; 2014 Dec; 65(6):757-63. PubMed ID: 25040445
[TBL] [Abstract][Full Text] [Related]
16. Clinical Significance of Subcellular Localization of Maspin in Patients with Pathological Stage IA Lung Adenocarcinoma.
Ohno T; Kubouchi Y; Wakahara M; Nosaka K; Sakabe T; Haruki T; Miwa K; Taniguchi Y; Nakamura H; Umekita Y
Anticancer Res; 2018 May; 38(5):3001-3007. PubMed ID: 29715131
[TBL] [Abstract][Full Text] [Related]
17. Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma.
Ladstein RG; Bachmann IM; Straume O; Akslen LA
BMC Cancer; 2010 Apr; 10():140. PubMed ID: 20398247
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of maspin and Ki-67 expression in transurethral resection specimens in patients with T1 bladder cancer.
Acikalin D; Oner U; Can C; Acikalin MF; Colak E
Tumori; 2012; 98(3):344-50. PubMed ID: 22825520
[TBL] [Abstract][Full Text] [Related]
19. High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma.
Nodin B; Fridberg M; Jonsson L; Bergman J; Uhlén M; Jirström K
Diagn Pathol; 2012 Jul; 7():82. PubMed ID: 22805320
[TBL] [Abstract][Full Text] [Related]
20. Shift from cytoplasmic to nuclear maspin expression correlates with shorter overall survival in node-negative colorectal cancer.
Märkl B; Arnholdt HM; Jähnig H; Schenkirsch G; Herrmann RA; Haude K; Spatz H; Anthuber M; Schlimok G; Oruzio D
Hum Pathol; 2010 Jul; 41(7):1024-33. PubMed ID: 20334895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
